249 related articles for article (PubMed ID: 36471257)
1. Neoadjuvant chemotherapy for patients with international federation of gynecology and obstetrics stages IB3 and IIA2 cervical cancer: a multicenter prospective trial.
Hu Y; Han Y; Shen Y; Chen J; Chen Y; Chen Y; Tang J; Xue M; Hong L; Cheng W; Wang D; Liang Z; Wang Y; Zhang Q; Xing H; Zhang Y; Yi C; Yu Z; Chen Y; Cui M; Ma C; Yang H; Li R; Long P; Zhao Y; Qu P; Tao G; Yang L; Wu S; Liu Z; Yang P; Lv W; Xie X; Ma D; Wang H; Li K
BMC Cancer; 2022 Dec; 22(1):1270. PubMed ID: 36471257
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer.
Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z
World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118
[TBL] [Abstract][Full Text] [Related]
3. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
4. Effect of neoadjuvant chemotherapy followed by radical surgery for FIGO stage IB2/IIA2 cervical cancer: A multi-center retrospective clinical study.
Zhao H; He Y; Zhu LR; Wang JL; Guo HY; Xu T; Wang YQ; Yao Y; Wu YM
Medicine (Baltimore); 2019 May; 98(21):e15604. PubMed ID: 31124937
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
Zeng J; Sun P; Ping Q; Jiang S; Hu Y
PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of effects and postoperative clinicopathological prognosis factors of neoadjuvant chemotherapy in patients with stage Ⅰb2 and Ⅱa2 squamous cell carcinoma of the cervix].
An JS; Zhao YX; Song Y; Li N; Huang MN; Li XG; Li B; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Oct; 54(10):673-679. PubMed ID: 31648443
[No Abstract] [Full Text] [Related]
7. Platinum-based neoadjuvant chemotherapy followed by radical surgery for cervical carcinoma international federation of gynecology and obstetrics stage IB2-IIB.
Minig L; Colombo N; Zanagnolo V; Landoni F; Bocciolone L; Cárdenas-Rebollo JM; Iodice S; Maggioni A
Int J Gynecol Cancer; 2013 Nov; 23(9):1647-54. PubMed ID: 24100590
[TBL] [Abstract][Full Text] [Related]
8. Efficacy Analysis of Neoadjuvant versus Adjuvant Cisplatin-Paclitaxel Regimens for Initial Treatment of FIGO Stages IB3 and IIA2 Cervical Cancer.
Tao W; Wang W; Zhai J; Guo L
Med Sci Monit; 2023 Dec; 29():e940545. PubMed ID: 38062672
[TBL] [Abstract][Full Text] [Related]
9. [Comparative analysis of neoadjuvant therapies in stage Ib2 and IIa2 cervical carcinoma].
Hu JL; Wu LY; Li N; Li XG; Huang MN; Zhang R
Zhonghua Fu Chan Ke Za Zhi; 2012 Jun; 47(6):452-7. PubMed ID: 22932113
[TBL] [Abstract][Full Text] [Related]
10. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
11. Radical Hysterectomy After Neoadjuvant Chemotherapy for Locally Bulky-Size Cervical Cancer: A Retrospective Comparative Analysis between the Robotic and Abdominal Approaches.
Liu CH; Lee YC; Lin JC; Chan IS; Lee NR; Chang WH; Liu WM; Wang PH
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31614465
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy efficacy and prognostic factors in 187 cervical cancer patients with IB2 and IIA2 stage.
Zou T; Zheng C; Zhang Z; Yu L; Fu C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):297-304. PubMed ID: 32386022
[TBL] [Abstract][Full Text] [Related]
13. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer.
Papadia A; Bellati F; Bogani G; Ditto A; Martinelli F; Lorusso D; Donfrancesco C; Gasparri ML; Raspagliesi F
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S944-51. PubMed ID: 26268452
[TBL] [Abstract][Full Text] [Related]
14. Comparison of survival outcomes of neoadjuvant therapy and direct surgery in IB2/IIA2 cervical adenocarcinoma: a retrospective study.
Ouyang P; Cai J; Gui L; Liu S; Wu NY; Wang J
Arch Gynecol Obstet; 2020 May; 301(5):1247-1255. PubMed ID: 32221709
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the clinical efficacy of different treatments based on radical surgery in stage Ⅰ b2 and Ⅱa2 cervical cancer: a prospective randomized control study].
Li X; Kong WM; Han C; Yan Z; Zhao H; Zhang WY; Wang JD
Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):524-9. PubMed ID: 27465872
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
Ngabonziza E; Ghebre R; DeBoer RJ; Ntasumbumuyange D; Magriples U; George J; Grover S; Bazzett-Matabele L
BMC Womens Health; 2024 Mar; 24(1):204. PubMed ID: 38555423
[TBL] [Abstract][Full Text] [Related]
17. Matched-case comparison of neoadjuvant chemotherapy in patients with FIGO stage IB1-IIB cervical cancer to establish selection criteria.
Hu T; Li S; Chen Y; Shen J; Li X; Huang K; Yang R; Wu L; Chen Z; Jia Y; Wang S; Cheng X; Han X; Lin Z; Xing H; Qu P; Cai H; Song X; Tian X; Xu H; Xu J; Zhang Q; Xi L; Deng D; Wang H; Wang S; Lv W; Wang C; Xie X; Ma D
Eur J Cancer; 2012 Oct; 48(15):2353-60. PubMed ID: 22503395
[TBL] [Abstract][Full Text] [Related]
18. CD34 and Bcl-2 as predictors for the efficacy of neoadjuvant chemotherapy in cervical cancer.
Lin Y; Li Z; Liu M; Ye H; He J; Chen J
Arch Gynecol Obstet; 2021 Aug; 304(2):495-501. PubMed ID: 33392721
[TBL] [Abstract][Full Text] [Related]
19. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of neoadjuvant chemotherapy in the treatment of locally advanced cervical cancer: A randomized multicenter study.
Yang Z; Chen D; Zhang J; Yao D; Gao K; Wang H; Liu C; Yu J; Li L
Gynecol Oncol; 2016 May; 141(2):231-239. PubMed ID: 26115978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
